WAVE Life Sciences (WVE) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Jones Trading Starts WAVE Life Sciences (WVE) at Buy
August 8, 2024 4:06 PM EDTJones Trading analyst Catherine Novack initiates coverage on WAVE Life Sciences (NASDAQ: WVE) with a Buy rating and a price target of $12.00.
The analyst comments "We are initiating coverage of Wave Life Sciences with a BUY rating and $12 price target. WVE's portfolio contains... More
